SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is generating significant buzz ahead of its upcoming R2 vehicle launch at SXSW, with investors focusing on leaked pricing and configurations that suggest a strategy of prioritizing higher-margin trims. While some community members express frustration over product timing and pricing expectations, the stock is seeing heightened activity following a positive analyst upgrade that highlights long-term demand potential.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax Technologies is experiencing a surge in trading activity as investors react to its role as a stealth supplier for Nvidia's AI-driven optical data center infrastructure. The community is actively debating the timing of mass production and the potential impact of co-packaged optics (CPO) on the company's long-term revenue growth.

Invesco DB US Dollar Index Trust - Invesco DB US Dollar Index Bullish Fund

Invesco DB US Dollar Index Bullish Fund

UUP is currently a focal point for investors as the market debates the potential impact of future Federal Reserve interest rate cuts on the greenback. Discussion is heavily driven by diverging macro signals and shifting safe-haven demand, with traders actively debating whether the dollar will face a long-term structural decline or find support amidst ongoing geopolitical and economic uncertainty.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is trending as investors weigh an improving launch trajectory for its flagship fibromyalgia treatment, Tonmya, against persistent concerns over cash burn and potential share dilution. The community remains deeply polarized, with some bulls highlighting recent formulary additions and strong prescription growth as signs of an impending re-rating, while bears focus on the historical pattern of capital raises and management's perceived lack of transparency.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing intense selling pressure and market uncertainty as investors react to a significant double-beat earnings report overshadowed by the surprise announcement that long-time CEO Shantanu Narayen will step down. The stock remains a polarizing battleground, with bulls highlighting its strong cash flow and AI-driven growth, while skeptical traders and bears argue that generative AI tools are rapidly commoditizing the company's core creative software ecosystem.

Wingstop, Inc. is a franchisor and chicken wings-focused restaurant. The firm is engaged in the flavor business offering cooked-to-order, hand-sauced, and tossed classic and boneless wings, tenders and chicken sandwiches in flavors, with signature sides, such as its seasoned fries and house made ranch and bleu cheese dips. The company was founded in 1994 and is headquartered in Dallas, TX.

Wingstop Inc

Wingstop is trending following an authorized $300 million share repurchase program, which has sparked intense debate among investors balancing the company's strong unit growth against concerns of domestic consumer exhaustion. While some traders view the stock as a prime opportunity for long-term growth and are capitalizing on the aggressive buybacks, others remain skeptical, citing elevated valuations and speculative concerns about the brand's long-term sustainability.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as the community eagerly anticipates upcoming live demonstrations of its external light source products at the major OFC industry conference. Investors are actively discussing the stock's potential for a significant re-rating, fueled by speculation over strategic partnerships and the company's production scaling efforts in the AI data center space.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is trending as investors rotate into the stock ahead of potential national security-linked government contracts and pharmaceutical expansion milestones. The community is actively discussing the company's improved balance sheet and the strategic pivot into regulated pharmaceutical products, with many holding out for long-term catalysts despite frustrations over limited management communication.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin (XCN) is currently trending as the community closely monitors the upcoming Goliath mainnet launch and tracks increased whale accumulation across multiple wallets. While sentiment is sharply divided between believers anticipating a significant breakthrough and skeptics labeling the recent price action as manipulative, discussions remain hyper-focused on the project's institutional connections and its potential for long-term growth.

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Rubrik Inc. is facing intense downward pressure following a series of sell-offs, despite the community highlighting strong earnings performance, revenue growth, and its critical role in AI-driven data resilience. Investors remain polarized, with many calling the stock significantly undervalued and an accumulation opportunity, while others express frustration over institutional selling and market-wide volatility impacting the cybersecurity sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ARS Pharmaceuticals Q4 Earnings Call Highlights

ARS Pharmaceuticals (NASDAQ:SPRY) executives used the company's fourth-quarter and full-year 2025 earnings call to outline early commercial progress for neffy, its needle-free epinephrine option for...

ARS Pharmaceuticals: Q4 Earnings Insights

ARS Pharmaceuticals, Inc. (SPRY) Reports Q4 Loss, Beats Revenue Estimates

ARS Pharmaceuticals, Inc. (SPRY) delivered earnings and revenue surprises of -0.96% and +9.10%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Exploring ARS Pharmaceuticals's Earnings Expectations

ARS Pharmaceuticals (SPRY) Expected to Announce Earnings on Monday

ARS Pharmaceuticals (NASDAQ:SPRY) will be releasing its Q4 2025 earnings before the market opens on Monday, March 9. (View Earnings Report at...

Canadian Natural to Report Q4 Earnings: What's in the Offing?

CNQ gears up to report Q4 earnings as lower price realizations and soft gas weigh on estimates despite record output and strong cash flow.

ARS Pharmaceuticals, Inc. (SPRY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

ARS Pharmaceuticals, Inc. (SPRY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ARS Pharmaceuticals (NASDAQ:SPRY) Upgraded at Zacks Research

Zacks Research upgraded ARS Pharmaceuticals from a "strong sell" rating to a "hold" rating in a research report on Wednesday...

Levin Capital Strategies L.P. Increases Holdings in ARS Pharmaceuticals, Inc. $SPRY

Levin Capital Strategies L.P. boosted its stake in shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Free Report) by 157.6% in the 3rd quarter, according to the company in its most recent disclosure...

CenterBook Partners LP Invests $5.15 Million in ARS Pharmaceuticals, Inc. $SPRY

CenterBook Partners LP acquired a new stake in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange...

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

Current Price	$8.24
Prev Close	$8.38
Open	$8.23
Dividend Yield	0.00%
50-Day Moving Average	$10.10
Beta	1.25
Avg. Volume	1.01M
PE Ratio	-4.82

52-Week High	$18.90
52-Week Low	$6.66
Market Capitalization	$832.11M
EPS (Annual)	-$1.74
Price to Book	7.28
Revenue Per Employee	$533,405.06

SPRY
ARS Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SPRY News

SPRYARS Pharmaceuticals Inc